SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001014108-22-000052
Filing Date
2022-02-14
Accepted
2022-02-14 16:02:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G, AMENDMENT 1 ten-sc13g_amendment1.htm SC 13G 58338
  Complete submission text file 0001014108-22-000052.txt   59605
Mailing Address P.O. BOX 1860 BENTONVILLE AR 72712
Business Address
Walton Thomas Layton (Filed by) CIK: 0001840680 (see all company filings)

Type: SC 13G

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Subject) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92757 | Film No.: 22631163
SIC: 2836 Biological Products, (No Diagnostic Substances)